An evaluation of the brain distribution of [(11)C]GSK1034702, a muscarinic-1 (M(1)) positive allosteric modulator in the living human brain using positron emission tomography

BACKGROUND: The ability to quantify the capacity of a central nervous system (CNS) drug to cross the human blood-brain barrier (BBB) provides valuable information for de-risking drug development of new molecules. Here, we present a study, where a suitable positron emission tomography (PET) ligand wa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EJNMMI Res
Main Authors: Ridler, Khanum, Cunningham, Vincent, Huiban, Mickael, Martarello, Laurent, Pampols-Maso, Sabina, Passchier, Jan, Gunn, Roger N, Searle, Graham, Abi-Dargham, Anissa, Slifstein, Mark, Watson, Jeanette, Laruelle, Marc, Rabiner, Eugenii A
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2014
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4452589/
https://ncbi.nlm.nih.gov/pubmed/26116126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-014-0066-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados